Résumé / Abstract

226 - Transmission anténatale du virus de l'hépatite B en zone de prévalence modérée du VIH, Ouagadougou, Burkina Faso.

Antenatal transmission of hepatitis B virus in an area of HIV moderate prevalence, Burkina Faso.

L. Sangaré, R. Sombié, A.W. Combasséré, A. Kouanda, D. Kania, O. Zerbo & J. Lankoandé

The aim of this study was to assess antenatal transmission of hepatitis B virus in a context of moderate prevalence of HIV, in Burkina Faso. Among 360 counselled pregnant women for HIV and HBV testing, 307 were voluntarily enrolled at their last antenatal clinic at the university hospital, in Ouagadougou. Blood samples were collected from all the 307 mothers and tested for HBsAg, HBeAg and antibodies to HIV. Blood samples were collected from 313 newborn infants 24h after birth and screened for HBV. Data from mothers and newborn babies were collected and analysed using the EPI Info 2002 software. Values for P<0.05 were considered statistically significant. HBsAg were found in 35 (11.4%) mothers, including 7 with HBeAg and 6 co-infected by both HIV and HBV. Seven babies born to 13 carrier mothers for HBsAg and HBeAg had HBsAg versus 6 born to 22 HBsAg carrier mothers HBeAg-negative. HBsAg was detected in 4 babies born to 6 HIV/HBV co-infected mothers versus 9 born to 29 mothers with HBsAg and HIV-negative. HIV infection, HBeAg and mothers excision were significantly associated with mother-to-child transmission of HBV (p<0.02). HBV antenatal transmission was important in Ouagadougou and occurred 2.5 times more from HIV co-infected mothers than in HIV-negative mothers to newborn babies. These results showed the need of implementation of national programme for HBV screening and immunisation in Burkina Faso.

VHB - transmission anténatale - VIH - femme enceinte - hôpital - Ouagadougou - Burkina Faso - Afrique intertropicale

The aim of this study was to assess antenatal transmission of hepatitis B virus in a context of moderate prevalence of HIV, in Burkina Faso. Among 360 counselled pregnant women for HIV and HBV testing, 307 were voluntarily enrolled at their last antenatal clinic at the university hospital, in Ouagadougou. Blood samples were collected from all the 307 mothers and tested for HBsAg, HBeAg and antibodies to HIV. Blood samples were collected from 313 newborns in the 24 hours after birth and screened for HBV. Data from mothers and newborns were collected and analysed using the EPI Info 2002 software. Values for p<0.05 were considered statistically significant. HBsAg were found in 35 (11.4%) mothers, including 7 with HBeAg and 6 co-infected by both HIV and HBV. Seven babies born to 13 carrier mothers for HBsAg and HBeAg had HBsAg versus 6 born to 22 HBsAg carrier mothers HBeAg-negative. HBsAg was detected in 4 babies born to 6 HIV/HBV co-infected mothers versus 9 born to 29 mothers with HBsAg and HIV-negative. HIV infection, HBeAg and mothers excision were significantly associated with mother-to-child transmission of HBV (p<0.02). HBV antenatal transmission was important in Ouagadougou and it occurred 2.5 folds more from HIV co-infected mothers than in HIV-negative mothers to newborns. These results showed the need of the implementation of national programme for HBV screening and immunisation in Burkina Faso.

VHB - transmission anténatale - VIH - femme enceinte - hôpital - Ouagadougou - Burkina Faso - Afrique intertropicale

Références bibliographiques

  • 1. HOU J, LIU Z & GU F - Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci, 2005, 2, 50-57.
  • 2. ILBOUDO D, SAWADOGO A & SIMPORÉ J - Transmission mère-enfant du virus de l'hépatite B à Ouagadougou, Burkina Faso. Méd Trop, 2002, 62, 99-100.
  • 3. NACRO B, DAO B, DAHOUROU H, HIEN F, CHARPENTIER-GAUTIER L et al. - Portage de l'antigène HBs chez les femmes enceintes à Bobo-Dioulasso (Burkina Faso). Dakar Méd, 2000, 45, 188-190.
  • 4. Programme commun des Nations Unies sur le VIH/sida (ONUSIDA) - Organisation Mondiale de la Santé (OMS). - Recommandations concernant le choix et l'utilisation des tests de mise en evidence des anticorps anti-VIH-Version révisée. Relev Epidemiol Hebdo, 1997, 72, 81-87.
  • 5. PUOTI M, AIROLDI M, BRUNO R, ZANINI B, SPINETTI A et al. - Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects. AIDS Rev, 2002, 4, 27-35.
  • 6. RANGER-ROGEZ S & DENIS F - Hepatitis B mother-to-child transmission. Expert Rev Anti-Infective Ther, 2004, 2, 133-145.
  • 7. SIDIBÉ S, SACKO BY & TRAORÉ I - Prévalence des marqueurs sérologiques du virus de l'hépatite B chez les femmes enceintes dans le district de Bamako, Mali. Bull Soc Pathol Exot, 2001, 94, 339-341. [http://www.pathexo.fr/SPE/abstract.php?id_article=3843]
  • 8. SIMPORE J, GRANATO M, SANTARELLI R, NSME RA, COLUZZI M et al. - Prevalence of infection by HHV-8, HIV, HCV and HBV among pregnant women in Burkina Faso. J Clin Virol, 2004, 31, 78-80.
  • 9. SIMPORE J, SAVADOGO A ILBOUDO D, NADAMBEGA MC, ESPOSITO M et al. - Toxoplasma gondii, HCV and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso. J Med Virol, 2006, 78, 730-733.
  • 10. WHO - Hepatitis B. WHO/CDS/CSR/LYO/2002.2. WHO, Geneva, 2002.
  • 11. XU DZ, YAN YP, CHOI BC, XU JQ, MEN K et al. - Risk factors and mechanism of transplacental transmission of hepatitis B virus : a case-control study. J Med Virol, 2002, 67, 20-26.
  • 12. ZHANG SL, YUE YF, BAI GQ, SHI L & JIANG H. Mechanism of intrauterine infection of hepatitis B virus. World J Gastroenterol, 2004, 10, 437-438.